# Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women

> **NCT02431273** · EARLY_PHASE1 · COMPLETED · sponsor: **Auritec Pharmaceuticals** · enrollment: 10 (actual)

## Conditions studied

- Human Immunodeficiency Virus (HIV) Prophylaxis

## Interventions

- **DRUG:** TDF IVR
- **DRUG:** TDF-FTC IVR
- **DRUG:** TDF-FTC-MVC IVR

## Key facts

- **NCT ID:** NCT02431273
- **Lead sponsor:** Auritec Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-07-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02431273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02431273, "Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02431273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*